Digoxin revisited.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  QJM : monthly journal of the Association of Physicians

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/qjmed/91.4.259PMID 9666948
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The effect of digoxin on mortality and morbidity in patients with heart failure.

  1997cited by this paper
• Effects of increasing maintenance dose of digoxin on left ventricular function and neurohormones in patients with chronic heart failure treated with diuretics and angiotensin-converting enzyme inhibitors.

  1995cited by this paper
• Effect of long-term digoxin therapy on autonomic function in patients with chronic heart failure.

  1995cited by this paper
• Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study.

  1993cited by this paper
• Effects of digoxin and enalapril on heart period variability and response to head-up tilt in normal subjects.

  1993cited by this paper
• Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT).

  1993cited by this paper
• Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group.

  1993cited by this paper
• The development of positive inotropic agents for chronic heart failure: how have we gone astray?

  1993cited by this paper
• Effect of digitalis on norepinephrine kinetics in congestive heart failure.

  1992cited by this paper
• Clinical use of serum digoxin concentrations.

  1992cited by this paper
• Digitalis and neurohormonal abnormalities in heart failure and implications for therapy.

  1992cited by this paper
• Recognition and management of digitalis toxicity.

  1992cited by this paper
• Pharmacokinetics of Digoxin and Main Metabolites/Derivatives in Healthy Humans

  1991cited by this paper
• Digoxin-induced vasoconstriction of normal and atherosclerotic epicardial coronary arteries.

  1991cited by this paper
• Effect of digoxin on contractility and symptoms in infants with a large ventricular septal defect.

  1991cited by this paper
• Digoxin. A neurohormonal modulator in heart failure?

  1991cited by this paper
• Inotropic therapy for heart failure: paradise postponed.

  1989cited by this paper
• Sympathoinhibitory responses to digitalis glycosides in heart failure patients. Direct evidence from sympathetic neural recordings.

  1989cited by this paper
• A controlled trial of digoxin in congestive heart failure.

  1988cited by this paper
• Digitalis: dead or alive?

  1988cited by this paper
• Acute effects of digoxin on total systemic vascular resistance in congestive heart failure due to dilated cardiomyopathy: a hemodynamic-hormonal study.

  1985cited by this paper
• Digitalis and the autonomic nervous system.

  1985cited by this paper
• Effect of digitalis treatment on survival after acute myocardial infarction.

  1985cited by this paper
• The quantitative relationship between twitch tension and intracellular sodium activity in sheep cardiac Purkinje fibres.

  1984cited by this paper
• Inactivation of digoxin by the gut flora: reversal by antibiotic therapy.

  1981cited by this paper
• Dose-response relation between therapeutic levels of serum digoxin and systolic time intervals.

  1975cited by this paper
• Serum digoxin in patients with thyroid disease.

  1975cited by this paper
• Digitalis intoxication. A prospective clinical study with serum level correlations.

  1971cited by this paper
• STUDIES ON DIGITALIS. X. EFFECTS OF OUABAIN ON FOREARM VASCULAR RESISTANCE AND VENOUS TONE IN NORMAL SUBJECTS AND IN PATIENTS IN HEART FAILURE.

  1964cited by this paper

• Motnje srčnega ritma zaradi hiperdigitalisnega stanja in akutna obravnava zastrupljencev z digoksinom

  2024cites this paper
• Impact of Severe Yellow Oleander Poisoning on Cardiac Function and Hemodynamics

  2019cites this paper
• New applications of oleanolic acid and its derivatives as cardioprotective agents: A review of their therapeutic perspectives.

  2019cites this paper
• Cholestyramine , A Cost-Effective Yet Efficacious AntiDote in Digoxin Toxicity

  2019cites this paper
• New Indices for Ethnotoxicological Assessment of Medicinal Plants: Example of Tafilalet Region, Morocco.

  2019cites this paper
• Cardenolides from the Apocynaceae family and their anticancer activity.

  2016cites this paper
• Some Drugs and Herbal Products.

  2016cites this paper
• Role of digoxin in controlling the ventricular rate during atrial fibrillation: a systematic review and a rethinking

  2014cites this paper
• Detecting metabolites of different transition metallithospermate B complexes after intravenous injection in rats

  2014cites this paper
• Digoxin - time to take the gloves off?

  2013cites this paper
• Enhancing the potency of lithospermate B for inhibiting Na+/K+-ATPase activity by forming transition metal ion complexes

  2013cites this paper
• Absence of Clinically Relevant Interactions between Rivaroxaban - an Oral, Direct Factor Xa Inhibitor - and Digoxin or Atorvastatin in Healthy Subjects

  2012cites this paper
• Inhibition of Na(+)/K(+) -ATPase by antcins, unique steroid-like compounds in Antrodia camphorate.

  2012cites this paper
• The H₁-H₂ domain of the α₁ isoform of Na+-K+-ATPase is involved in ouabain toxicity in rat ventricular myocytes.

  2012cites this paper
• Active ingredients in Chinese medicines promoting blood circulation as Na+/K+-ATPase inhibitors

  2011cites this paper
• Bradyarrhythmia caused by ginseng in a patient with chronic kidney disease.

  2010cites this paper
• Steroid-like compounds in Chinese medicines promote blood circulation via inhibition of Na+/K+-ATPase

  2010cites this paper
• Magnesium lithospermate B extracted from Salvia miltiorrhiza elevats intracellular Ca2+ level in SH-SY5Y cells

  2010cites this paper
• Active compounds in Chinese herbs and medicinal animal products which promote blood circulation via inhibition of Na+, K+-ATPase.

  2010cites this paper
• Ribosomal protein L3 mediated the transport of digoxin in Xenopus laevis oocyte.

  2010cites this paper
• Effect of sugar positions in ginsenosides and their inhibitory potency on Na+/K+-ATPase activity

  2009cites this paper
• Management of atrial fibrillation

  2007cites this paper
• Magnesium lithospermate B possesses inhibitory activity on Na+,K+-ATPase and neuroprotective effects against ischemic stroke

  2007cites this paper
• Identification and characterization of novel sodium/potassium-ATPase inhibitors by virtual screening of a compound database.

  2007cites this paper
• Management of atrial fibrillation.

  2007cites this paper
• The influence of potassium ion (K+) on digoxin-induced inhibition of porcine cerebral cortex Na+/K+-ATPase

  2006cites this paper
• Rate control in the medical management of atrial fibrillation

  2006cites this paper
• Interactions between cardiac glycosides and sodium/potassium-ATPase: three-dimensional structure-activity relationship models for ligand binding to the E2-Pi form of the enzyme versus activity inhibition.

  2005cites this paper
• [Digoxin assay: results of 10 years of intralaboratory controls].

  2005cites this paper
• Elucidation of the Na+, K+-ATPase digitalis binding site.

  2005cites this paper
• Molecular modeling of cardiac glycoside binding by the human sequence monoclonal antibody 1B3

  2005cites this paper
• Emergency management of atrial fibrillation

  2003cites this paper
• Role of Digoxin in Older Adults with Heart Failure

  2002cites this paper
• The Journal of Toxicological Sciences

  2002cites this paper
• Inappropriate use of digoxin in older hospitalized heart failure patients.

  2002cites this paper
• Digoxin: a drug whose time has gone?

  2001cites this paper
• Paroxysmal atrial fibrillation.

  2001cites this paper
• Managing atrial fibrillation in the Accident and Emergency department.

  2001cites this paper
• Review of common adverse effects of selected antiarrhythmic drugs.

  2000cites this paper
• How Would I Manage a 60–year-old Woman Presenting with Atrial Fibrillation?

  1999cites this paper
• Digoxin revisited.

  1998cites this paper
• Proprietary names for digoxin : Cardigox

  year unknowncites this paper